Independent Walking for Brain Health
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03058146 |
Recruitment Status :
Terminated
(COVID-19)
First Posted : February 20, 2017
Last Update Posted : September 2, 2022
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Physical Activity Aging | Behavioral: Mobile Health Walking Condition Behavioral: Healthy Aging Education Condition | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 55 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Randomized Controlled Trial with ongoing enrollment into each arm (individual intervention) |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Novel Mobile Health Exercise Intervention in Aging: Brain Perfusion and Cognition |
Actual Study Start Date : | June 7, 2017 |
Actual Primary Completion Date : | March 15, 2020 |
Actual Study Completion Date : | March 15, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Mobile Health Walking Condition
Physically inactive older adults in this condition (N=30) will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week.
|
Behavioral: Mobile Health Walking Condition
Physically inactive older adults in this condition (N=30) will perform 3 months of prescribed brisk walking (to increase cardio respiratory fitness) in their real world environments, using mobile health (mHealth) devices during each exercise session to achieve and maintain a minimum of 150 minutes of moderate to vigorous physical activity (MVPA) per week. |
Active Comparator: Healthy Aging Education Condition
The education control condition (N=30) will provide participants with printed materials and homework assignments on issues related to successful aging, such as nutrition, social activity, cognitive and social engagement.
|
Behavioral: Healthy Aging Education Condition
The education control condition (N=30) will provide participants with printed materials and homework assignments on issues related to successful aging, such as nutrition, social activity, cognitive and social engagement. |
- Moderate to Vigorous Physical Activity [ Time Frame: 0, 6 weeks, 12 weeks ]Change in moderate to vigorous levels of physical activity (defined as >1952 accelerometer counts per minute)
- Cerebral Blood Flow (hippocampal and frontal) [ Time Frame: 0 and 12 weeks ]Change in cerebral blood flow measured with arterial spin labeling MRI
- Memory Function [ Time Frame: 0, 6 weeks, and 12 weeks ]Memory Composite (average of z-scores) = Rey Auditory Verbal Learning Test (short and long delay free recall); Wechsler Memory Scale-R Logical Memory (immediate and delay recall).
- Executive Function [ Time Frame: 0, 6 weeks, 12 weeks ]Executive Function Composite (average of z-scores) = Trail Making Test Part B minus Trail Making Test Part A, Stroop Color Word Trial, and verbal fluency (letters FAS).
- Cardiorespiratory Fitness [ Time Frame: 0 and 12 weeks ]Change in total time to 85% of estimated maximal heart rate via sub-maximal treadmill test

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years to 80 Years (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Men and women between the ages of 65-80
- Ability to obtain a signed physician's clearance for participation in this study
- English-speaking as needed to complete cognitive testing and follow study procedures
- Cognitively normal (based on comprehensive neuropsychological assessment)
- No contraindications for Magnetic Resonance Imaging (MRI)
- Must be ambulatory and able to walk independently
Exclusion Criteria:
- History of head injury involving loss of consciousness within the past 6 months and/or history of severe traumatic brain injury
- Major neurological disorders (dementia, multiple sclerosis, epilepsy, etc)
- Chronic major psychiatric disorders (schizophrenia, major recurrent affective disorder)
- History of major vascular events (myocardial infarction, stroke, etc),
- History of diabetes
- History of falls in the last year resulting in hospitalization
- Unstable or poorly controlled medical problems e.g. heart failure, diabetes (poorly controlled or on insulin), uncontrolled hypertension, pulmonary disease with hypoxia or hypercapnia, significant liver problems or renal failure, treatment of cancer in the past 2 years (other than non-melanoma skin cancer), HIV positive
- Objective evidence of cognitive impairment based on neuropsychological assessment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03058146
United States, California | |
University of California, San Diego | |
La Jolla, California, United States, 92093 |
Principal Investigator: | Zvinka Z Zlatar, PhD | University of California, San Diego |
Responsible Party: | Zvinka Z. Zlatar, Assistant Adjunct Professor, University of California, San Diego |
ClinicalTrials.gov Identifier: | NCT03058146 |
Other Study ID Numbers: |
20153238 K23AG049906 ( U.S. NIH Grant/Contract ) |
First Posted: | February 20, 2017 Key Record Dates |
Last Update Posted: | September 2, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Access to databases and associated software tools generated under the project will be available for educational, research and non-profit purposes. Such access will be provided using web-based applications, as appropriate. Publication of data shall occur during and at the end of the project, consistent with normal scientific practices. Research data which documents, supports and validates research findings will be made available after the main findings from the final research data set have been accepted for publication. Such research data will be redacted to prevent the disclosure of personal identifiers. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Exercise Fitness Physical Activity Cognitive Aging Cerebral Blood Flow |
Brain Imaging Unsupervised Intervention Mobile Health Free-living exercise intervention |